🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the efficacy, safety, and tolerab...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-07-21
Trial ID
NCT04732117
Treatments Being Tested
This study will establish whether prolonged chronic dosing with secukinumab...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2023-03-28
Trial ID
NCT05622708
Treatments Being Tested
The main objective of this study is to evaluate the efficacy and safety of ...
Status
Completed
Location
Advanced Research Associates - Glendale /ID# 204335
Start Date
2018-05-08
Trial ID
NCT03478787
Treatments Being Tested
The purpose of this study was to demonstrate efficacy of autoinjector admin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-10-17
Trial ID
NCT01636687
Treatments Being Tested
The purpose of this study is to assess long term safety in participants who...
Status
Recruiting
Location
Providence Medical Foundation
Start Date
2020-12-22
Trial ID
NCT04638647
Treatments Being Tested
The purpose of this study was to assess the clinical efficacy, safety and t...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-03-22
Trial ID
NCT02750592
Treatments Being Tested
The purpose of this study was to demonstrate the clinical efficacy, safety ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-04-29
Trial ID
NCT02696031
Treatments Being Tested
This is a pilot study in which the the safety and feasibility of secukinuma...
Status
Completed
Location
Tufts Medical Center, Department of Dermatology
Start Date
2016-07-11
Trial ID
NCT03099980
Treatments Being Tested
The aim of this study was to describe the effect of direct IL-17A inhibitio...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-01-14
Trial ID
NCT03553823
Treatments Being Tested
The study will assess the safety and efficacy of intravenous (10mg/kg) and ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-12
Trial ID
NCT01412944
Treatments Being Tested